vimarsana.com

Page 11 - பிரிட்டன் கூட்டு குழு ஆன் தடுப்பூசி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indian coronavirus variant could become a big problem in UK, expert warns

India-related coronavirus variant could become a big problem in UK: expert - World News

2021-05-29 13:06:02 GMT2021-05-29 21:06:02(Beijing Time) Xinhua English LONDON, May 29 (Xinhua) The India-related coronavirus variant could pick up speed and become a big problem in Britain as the country further eases its lockdown, a British expert warned Saturday. Britain s fight against coronavirus could turn bad very, very quickly unless the government acts cautiously on easing lockdown further, professor Tim Gowers from the University of Cambridge told The Guardian newspaper. So I think if that s the way you re going to play things, then you should be very, very cautious about every step you take . And maybe everything (will) be okay, maybe the number of people who are vaccinated will be just enough, he said.

At London s Wembley, FA Cup is also a science study for post-pandemic crowds

At Britain s Wembley Stadium, the venerable FA Cup also a science study for post-pandemic crowds

At Britain’s Wembley Stadium, the venerable FA Cup is also a science study for post-pandemic crowds Karla Adam UP NEXT LONDON To the fans, the FA Cup final at Wembley Stadium is an all-important soccer match. It s also a science experiment with far-reaching implications about how to reopen society as the pandemic loosens its grip in some places. On Saturday afternoon, the British government was watching scientists watching fans watching Chelsea and Leicester City play in the final of the oldest national soccer tournament in the world. Prince William, the president of the English Football Association, was watching at the stadium in northwest London, too.

Britain, Germany in role reversal on AstraZeneca vaccine risks

Publishing date: May 07, 2021  •  22 hours ago  •  3 minute read  •  Article content LONDON/BERLIN Britain restricted the use of AstraZeneca’s COVID-19 vaccine on Friday while Germany said it would give the shot to anyone who wants it, in a risk-management role reversal that reflects the divergent progress of their vaccination campaigns. The shifts in guidance on the Anglo-Swedish drugmaker’s vector-based shot demonstrate just how hard it is for policy makers to weigh its benefits against risks in the form of very rare – yet occasionally fatal – cases of blood clotting. We apologize, but this video has failed to load. Try refreshing your browser, or

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.